Table 3.
Indications for parenteral iron therapy
Celiac disease and H. pylori infection should be considered if anemia remains refractory after specific (diet or triple therapy respectively) treatment.17
IRIDA indicates iron refractory iron deficiency anemia; and ESA, erythropoiesis stimulating agents.
* Ongoing clinical trials.
Adapted from Camaschella.14
